Yıl: 2021 Cilt: 55 Sayı: 1 Sayfa Aralığı: 53 - 56 Metin Dili: İngilizce DOI: 10.5152/j.aott.2021.20019 İndeks Tarihi: 30-09-2021

Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?

Öz:
Objective: The aims of this study were (1) to investigate the changes in the serum concentration of prophylactically administrated vancomycin in the perioperative period of revision hip arthroplasty in penicillin/cephalosporin-allergic patients, (2) to assess whether thepostoperative re-administration of vancomycin is needed, and (3) to determine the relationships of vancomycin serum concentration withblood loss, body weight, and fluid replacement in such patients.Methods: This study consisted of 29 patients (20 females, 9 males; mean age=63.3 years; age range=45-79 years) with a history of penicillin/cephalosporin allergy undergoing revision hip arthroplasty secondary to aseptic loosening or periprosthetic fractures. Serum vancomycinlevels were measured (1) before administration of vancomycin, (2) at the time of skin incision, (3) every 1,5 hours thereafter until the endof the operation, (4) during the skin closure, and (5) after three and 12 hours from the initial dosage. Data regarding body weight, amountsof intraoperative blood loss, fluid and blood replacements and postoperative wound drainage were recorded.Results: The average blood loss, fluid replacement, and drain volume were 1280.3±575.8 (500-2700) mL, 2922.6±768.8 (1700-4600) mL,and 480.2±163.7 (200-850) mL, respectively. The mean levels of serum vancomycin were 46.3±21.8 (14.1-80.7) mg/L at the time of skinincision, 17.9±4.7 (9.4-30.9) and 9.8±2.2 (4.3-13.8) mg/L after 1.5 and 3 hours from the beginning of the surgery and 5.1±1.1 (2.9-6.8)mg/Lafter 12th hour postoperatively. The measured vancomycin levels were below the effective serum concentrations (< 5 mg/L) for 18 patients at 12 hours the administration of the first dose. A moderate level negative correlation between the blood loss/body weight ratio andvancomycin levels was found (p=0.004, r=-0.493). Predictive ROC curve analysis resulted in determining a blood loss volume higher than1150 ml and a blood loss/body weight ratio higher than 18,5 is significant to estimate the vancomycin level below the minimum effectiveserum level at 12th hour postoperatively (AUC=0.793±0.16, p=0.009, AUC=0.753) 26±0.12, p=0.025, respectively).Conclusion: Evidence from this study has indicated vancomycin concentration at 12th hour is below the effective level in most patients.Thus, earlier repetitive infusion of vancomycin seems to be necessary in penicillin/cephalosporin-allergic patients undergoing revisionhip arthroplasty, especially in those with high blood loss.Level of Evidence: Level III, Therapeutic Study
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
  • 1. Alp E, Cevahir F, Ersoy S, Güney A. Incidence and economic burden of prosthetic joint infections in a university hospital: A report from a middle-income country. J Infect Public Health 2016; 9: 494-8.
  • 2. Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev 2014; 27: 302- 45.
  • 3. Rajaee SS, Campbell JC, Mirocha J, Paiement GD. Increasing burden of total hip arthroplasty revisions in patients between 45 and 64 years of age. J Bone Joint Surg Am 2018; 100: 449-58.
  • 4. Ong KL, Kurtz SM, Lau E, Bozic KJ, Berry DJ, Parvizi J. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009; 24(6 Suppl): 105-9.
  • 5. Bohl DD, Samuel AM, Basques BA, Della Valle CJ, Levine BR, Grauer JN. How much do adverse event rates differ between primary and revision total joint arthroplasty? J Arthroplasty 2016; 31: 596-602.
  • 6. Schwarz EM, Parvizi J, Gehrke T, et al. 2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions. J Orthop Res 2019; 37: 997-1006.
  • 7. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 2009; 66: 82-98.
  • 8. Meter JJ, Polly DW Jr, Brueckner RP, Tenuta JJ, Asplund L, Hopkinson WJ. Effect of intraoperative blood loss on the serum level of cefazolin in patients managed with total hip arthroplasty. A prospective, controlled study. J Bone Joint Surg Am 1996; 78: 1201-5.
  • 9. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 2017; 152: 784-91.
  • 10. Larsson AJ, Walker KJ, Raddatz JK, Rotschafer JC. The concentration-independent effect of monoexponential and biexponential decay in vancomycin concentrations on the killing of Staphylococcus aureus under aerobic and anaerobic conditions. J Antimicrob Chemother 1996; 38: 589-97.
  • 11. James CW, Gurk-Turner C. Recommendations for monitoring serum vancomycin concentrations. Proc (Bayl Univ Med Cent) 2001; 14: 189-90.
  • 12. Eren B, Karagöz Güzey F, Kitiş S, Özkan N, Korkut C. The effectiveness of pedicle screw immersion in vancomycin and ceftriaxone solution for the prevention of postoperative spinal infection: A prospective comparative study. Acta Orthop Traumatol Turc 2018; 52: 289-93.
  • 13. Theologis AA, Demirkıran G, Callahan M, Pekmezci M, Ames C, Deviren V. Local intrawound vancomycin powder decreases the risk of surgical site infections in complex adult deformity reconstruction: A cost analysis. Spine 2014; 39: 1875-80.
  • 14. Eshkenazi AU, Garti A, Tamir L, Hendel D. Serum and synovial vancomycin concentrations following prophylactic administration in knee arthroplasty. Am J Knee Surg 2001; 14: 221-3.
  • 15. Swoboda SM, Merz C, Kostuik J, Trentler B, Lipsett PA. Does intraoperative blood loss affect antibiotic serum and tissue concentrations? Arch Surg 1996; 131: 1165-71; discussion 71-2.
  • 16. O’Brien TF. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 2002; 34 Suppl 3: S78-84.
  • 17. Catanzano A, Phillips M, Dubrovskaya Y, Hutzler L, Bosco J, 3rd. The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA. Iowa Orthop J 2014; 34: 111-7.
  • 18. Kheir MM, Tan TL, Azboy I, Tan DD, Parvizi J. Vancomycin prophylaxis for total joint arthroplasty: Incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin. Clin Orthop Relat Res 2017; 475: 1767-74.
  • 19. Kim YW. Antimicrobial-induced Electrolyte and Acid-Base Disturbances. Electrolyte Blood Press 2007; 5: 111-5.
  • 20. Bernier SP, Surette MG. Concentration-dependent activity of antibiotics in natural environments. Front Microbiol 2013; 4: 20.
  • 21. Zelenitsky SA, Ariano RE, Harding GKM, Silverman RE. Antibiotic pharmacodynamics in surgical prophylaxis: An association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 2002; 46: 3026-30.
APA Caglar O, Kaymakoglu M, cil a, ATILLA B, SARICAOGLU F, TOKGOZOGLU A (2021). Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. , 53 - 56. 10.5152/j.aott.2021.20019
Chicago Caglar Omur,Kaymakoglu Mehmet,cil akin,ATILLA BULENT,SARICAOGLU FATMA,TOKGOZOGLU AHMET MAZHAR Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. (2021): 53 - 56. 10.5152/j.aott.2021.20019
MLA Caglar Omur,Kaymakoglu Mehmet,cil akin,ATILLA BULENT,SARICAOGLU FATMA,TOKGOZOGLU AHMET MAZHAR Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. , 2021, ss.53 - 56. 10.5152/j.aott.2021.20019
AMA Caglar O,Kaymakoglu M,cil a,ATILLA B,SARICAOGLU F,TOKGOZOGLU A Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. . 2021; 53 - 56. 10.5152/j.aott.2021.20019
Vancouver Caglar O,Kaymakoglu M,cil a,ATILLA B,SARICAOGLU F,TOKGOZOGLU A Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. . 2021; 53 - 56. 10.5152/j.aott.2021.20019
IEEE Caglar O,Kaymakoglu M,cil a,ATILLA B,SARICAOGLU F,TOKGOZOGLU A "Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?." , ss.53 - 56, 2021. 10.5152/j.aott.2021.20019
ISNAD Caglar, Omur vd. "Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?". (2021), 53-56. https://doi.org/10.5152/j.aott.2021.20019
APA Caglar O, Kaymakoglu M, cil a, ATILLA B, SARICAOGLU F, TOKGOZOGLU A (2021). Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. Acta Orthopaedica et Traumatologica Turcica, 55(1), 53 - 56. 10.5152/j.aott.2021.20019
Chicago Caglar Omur,Kaymakoglu Mehmet,cil akin,ATILLA BULENT,SARICAOGLU FATMA,TOKGOZOGLU AHMET MAZHAR Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. Acta Orthopaedica et Traumatologica Turcica 55, no.1 (2021): 53 - 56. 10.5152/j.aott.2021.20019
MLA Caglar Omur,Kaymakoglu Mehmet,cil akin,ATILLA BULENT,SARICAOGLU FATMA,TOKGOZOGLU AHMET MAZHAR Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. Acta Orthopaedica et Traumatologica Turcica, vol.55, no.1, 2021, ss.53 - 56. 10.5152/j.aott.2021.20019
AMA Caglar O,Kaymakoglu M,cil a,ATILLA B,SARICAOGLU F,TOKGOZOGLU A Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. Acta Orthopaedica et Traumatologica Turcica. 2021; 55(1): 53 - 56. 10.5152/j.aott.2021.20019
Vancouver Caglar O,Kaymakoglu M,cil a,ATILLA B,SARICAOGLU F,TOKGOZOGLU A Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?. Acta Orthopaedica et Traumatologica Turcica. 2021; 55(1): 53 - 56. 10.5152/j.aott.2021.20019
IEEE Caglar O,Kaymakoglu M,cil a,ATILLA B,SARICAOGLU F,TOKGOZOGLU A "Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?." Acta Orthopaedica et Traumatologica Turcica, 55, ss.53 - 56, 2021. 10.5152/j.aott.2021.20019
ISNAD Caglar, Omur vd. "Vancomycin prophylaxis for revision hip arthroplasty in penicillin and cephalosporin sensitive patients: Is dose adjustment necessary in accordance with blood loss and fluid replacement?". Acta Orthopaedica et Traumatologica Turcica 55/1 (2021), 53-56. https://doi.org/10.5152/j.aott.2021.20019